Article
The Potential Therapeutic Applications of CRISPR/Cas9 in the Treatment of Gastrointestinal Cancers.
Current molecular medicine - 1 Jan 2025
Mehrabadi Shima, Izadi Faezeh Salmani, Pasha Shiva, Pourali Roozbeh, Khazaei Majid, Hassanian Seyed Mahdi, Ferns Gordon A, Avan Amir
Abstract excerpt
Gastrointestinal (GI) cancer is one the most prevalent types of cancer. Despite current chemotherapy's success, patients with GI cancer continue to have a dismal outcome. The onset and progression of cancer are caused by alterations and the abnormal expression of several families of genes, like tumor-suppressor genes, oncogenes, and chemotherapy-resistant genes. The final purpose of tumor therapy is to inhibit...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
